Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
4.237
-0.413 (-8.88%)
At close: Jan 14, 2025, 4:00 PM
4.130
-0.107 (-2.53%)
After-hours: Jan 14, 2025, 4:01 PM EST
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $77.50 million as of January 15, 2025. Its market cap has decreased by -21.22% in one year.
Market Cap
77.50M
Enterprise Value
59.40M
1-Year Change
-21.22%
Ranking
Category
Stock Price
$4.24
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $77.50M, a decrease of -62.88%. That is a compound annual growth rate of -27.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2025 | 85.05M | 6.90% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 718.08B |
| UnitedHealth Group | 498.00B |
| Novo Nordisk | 372.55B |
| Johnson & Johnson | 347.83B |
| AbbVie | 312.32B |
| Merck & Co. | 255.44B |
| Thermo Fisher Scientific | 212.49B |
| AstraZeneca | 204.00B |